25 May 2013
Keywords: advent, generic, gabapentin, impacts, neuropathic, pain, market
Article | 18 July 2005
US Neuropathic Pain, a new report which examines the effects of the entry of generic competition on world drug leader ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 July 2005
24 May 2013
© 2013 thepharmaletter.com